Bokf, Na Edwards Lifesciences Corp Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bokf, Na holds 26,495 shares of EW stock, worth $1.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

26,495

Previous 37,993 30.26%

Holding current value

$1.8 Million

Previous $3.51 Million 50.19%

% of portfolio

0.03%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $686,430 - $1.08 Million	-11,498 Reduced 30.26%	26,495 $1.75 Million
Q2 2024 Aug 07, 2024	SELL	$84.3 - $94.31 $134,037 - $149,952	-1,590 Reduced 4.02%	37,993 $3.51 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $234,811 - $309,327	-3,237 Reduced 7.56%	39,583 $3.78 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $98,859 - $124,571	1,602 Added 3.89%	42,820 $3.27 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $216,500 - $291,812	3,125 Added 8.2%	41,218 $2.86 Million
Q2 2023 Aug 21, 2023	SELL	$81.41 - $94.33 $361,378 - $418,730	-4,439 Reduced 10.44%	38,093 $3.59 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $357,116 - $406,408	-4,809 Reduced 10.16%	42,532 $3.52 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $955,517 - $1.22 Million	-13,990 Reduced 22.81%	47,341 $3.53 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $233,930 - $304,703	-2,840 Reduced 4.43%	61,331 $5.07 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $38,838 - $57,593	-449 Reduced 0.69%	64,171 $6.1 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $214,727 - $270,284	-2,106 Reduced 3.16%	64,620 $7.61 Million
Q4 2021 Mar 11, 2022	BUY	$106.37 - $130.68 $855,533 - $1.05 Million	8,043 Added 13.71%	66,726 $8.65 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $578,868 - $690,468	5,625 Added 10.6%	58,683 $6.64 Million
Q1 2021 Apr 21, 2021	BUY	$78.68 - $90.67 $428,491 - $493,788	5,446 Added 11.44%	53,058 $4.44 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $504,840 - $642,441	-7,042 Reduced 12.88%	47,612 $4.34 Million
Q3 2020 Oct 30, 2020	SELL	$67.19 - $87.44 $1.3 Million - $1.69 Million	-19,306 Reduced 26.1%	54,654 $4.36 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $2.65 Million - $3.54 Million	46,043 Added 164.93%	73,960 $5.11 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $48,217 - $74,520	-920 Reduced 3.19%	27,917 $5.27 Million
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $229,440 - $262,688	-3,200 Reduced 9.99%	28,837 $6.73 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $321,291 - $393,744	-5,220 Reduced 14.01%	32,037 $7.05 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $702,268 - $811,501	-12,599 Reduced 25.27%	37,257 $6.88 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $208,034 - $278,233	-4,344 Reduced 8.01%	49,856 $9.54 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $16,754 - $20,555	-361 Reduced 0.66%	54,200 $8.3 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $127,320 - $161,671	2,786 Added 5.38%	54,561 $9.5 Million
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $750,388 - $906,830	17,677 Added 51.84%	51,775 $7.54 Million
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $979,770 - $1.25 Million	26,345 Added 339.8%	34,098 $4.76 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $912 - $1,063	-27 Reduced 0.35%	7,753 $873,000
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $3,701 - $3,960	-102 Reduced 1.29%	7,780 $850,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,882	7,882 $932,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account